SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-059157
Filing Date
2020-05-11
Accepted
2020-05-11 08:05:15
Documents
3
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2019166-1_8k.htm 8-K 23456
2 EXHIBIT 99.1 tm2019166d1_ex99-1.htm EX-99.1 34727
3 GRAPHIC tm2019166d1_ex99-1img01.jpg GRAPHIC 2912
  Complete submission text file 0001104659-20-059157.txt   63491
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38586 | Film No.: 20862690
SIC: 2836 Biological Products, (No Diagnostic Substances)